Unit of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland.
Thorax. 2018 Sep;73(9):825-832. doi: 10.1136/thoraxjnl-2017-211289. Epub 2018 May 2.
It has been debated, but not yet established, whether increased airway responsiveness can predict COPD. Recognising this link may help in identifying subjects at risk.
We studied prospectively whether airway responsiveness is associated with the risk of developing COPD.
We pooled data from two multicentre cohort studies that collected data from three time points using similar methods (European Community Respiratory Health Survey and Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults). We classified subjects (median age 37 years, 1st-3rd quartiles: 29-44) by their level of airway responsiveness using quintiles of methacholine dose-response slope at the first examination (1991-1994). Then, we excluded subjects with airflow obstruction at the second examination (1999-2003) and analysed incidence of COPD (postbronchodilator FEV/FVC below the lower limit of normal) at the third examination (2010-2014) as a function of responsiveness, adjusting for sex, age, education, body mass index, history of asthma, smoking, occupational exposures and indicators of airway calibre.
We observed 108 new cases of COPD among 4205 subjects during a median time of 9 years. Compared with the least responsive group (incidence rate 0.6 per 1000/year), adjusted incidence rate ratios for COPD ranged from 1.79 (95% CI 0.52 to 6.13) to 8.91 (95% CI 3.67 to 21.66) for increasing airway responsiveness. Similar dose-response associations were observed between smokers and non-smokers, and stronger associations were found among subjects without a history of asthma or asthma-like symptoms.
Our study suggests that increased airway responsiveness is an independent risk factor for COPD. Further research should clarify whether early treatment in patients with high responsiveness can slow down disease progression.
气道高反应性是否能预测 COPD 一直存在争议,但尚未确定。认识到这一联系可能有助于识别高危人群。
我们前瞻性研究气道高反应性与 COPD 发病风险的关系。
我们合并了两项多中心队列研究的数据,这些研究使用类似的方法在三个时间点收集数据(欧洲社区呼吸健康调查和瑞士空气污染与成人肺部和心脏疾病队列研究)。我们根据第一次检查时(1991-1994 年)乙酰甲胆碱剂量反应斜率的五分位值将受试者(中位年龄 37 岁,1 四分位数至 3 四分位数:29-44 岁)分为气道高反应性水平不同的组。然后,我们排除第二次检查时气流阻塞的受试者(1999-2003 年),并根据气道口径的指标,分析第三次检查(2010-2014 年)时 COPD(支气管扩张后 FEV/FVC 低于正常下限)的发生率,作为反应性的函数,调整性别、年龄、教育程度、体重指数、哮喘史、吸烟、职业暴露和气道口径指标。
在中位时间为 9 年的研究期间,我们观察到 4205 名受试者中有 108 例新发 COPD。与反应性最低的组(发生率为 0.6/1000 人/年)相比,气道高反应性增加的 COPD 发生率比值比范围为 1.79(95%可信区间 0.52 至 6.13)至 8.91(95%可信区间 3.67 至 21.66)。在吸烟者和非吸烟者中观察到类似的剂量反应关系,在无哮喘或哮喘样症状史的受试者中观察到更强的关联。
我们的研究表明,气道高反应性是 COPD 的一个独立危险因素。进一步的研究应阐明在高反应性患者中早期治疗是否能减缓疾病进展。